SLD 251

 

SLD 251

Thyroid-Lit. 51022
SHERMAN, E.J. et al.
Radiotherapy and paclitaxel plus pazopanib or Placebo in anaplastic thyroid cancer (NRG/RTOG 0912): A randomized, double-blind, placebo-controlled, multicentre, phase 2 trial

Thyroid-Lit. 51023
VAN DER SPOEL, E. et al.
Incidence and determinations of spontaneous normalization of subclinical hypothyroidism in older adults

Thyroid-Lit. 51024
ADAMS, R. et al.
Endogenous and exogenous thyrotoxicosis and risk of incident cognitive disorders in older adults

Thyroid-Lit. 51025
TORO-TOBON, D. et al.
Medical therapy in patients with moderate to severe, steroid-resistant, thyroid eye disease

Thyroid-Lit. 51026
WATERHOUSE, M. et al.
The effect of Vitamin D supplementation on hypothyroidism in the randomized controlled D-health trial.

Thyroid-Lit. 51027
BIONDI, B. et al.
Preliminary results of a double-blind randomized controlled trial evaluating the cardiometabolic effects of levothyroxine and liothyronine compared to levothyroxine with placebo in athyreotic low-risk thyroid cancer patients.

Thyroid-Lit. 51028
YAN, L. et al.
Five-year outcome between radiofrequency ablation vs surgery for unilateral multifocal papillary thyroid microcarcinoma.

Thyroid-Lit. 51029
BRIGANTE, G. et al.
Randomized double-blind placebo- controlled trial on levothyroxine and liothyronine combination therapy in totally thyroidectomized subjects: the LEVOLIO study.;

Thyroid-Lit. 51030
STOKLAND, A.-E.M. et al.
Outcomes of patients with Graves´ disease 25 years after initiating antithyroid drug therapy.

Thyroid-Lit. 51031
GRANI, G. et al.
A data-driven approach to refine predictions of differentiated thyroid cancer outcomes: a prospective multicentre study.

Thyroid-Lit. 51032
DOUGLAS, R.S. et al.
Efficacy and safety of Teprotumumab in patients with thyroid eye disease of long duration and low disease activity.

Thyroid-Lit. 51033
MINASSIAN, C. et al.
Preconception management of hyperthyroidism and thyroid status in subsequent pregnancy: a population-based cohort study.

 

Letzte Aktualisierung: 15.01.2025